Stents are metal scaffolding that are used to unblock a clogged channel and improve the flow of bile or blood through it. Biodegradable stents, also known as bioresorbable stents, are stents comprised of biodegradable materials such as polymers and metal that eliminate the need for stent removal and the negative side effects associated with traditional stents. Biodegradable polymers evaluated for stent manufacture are polylactic acid (PLA), poly-DL-lactic acid (PDLLA), poly-L-lactic acid (PLLA), poly-DL-lactide-co-glycolide (PDLGA), poly-lactic-co glycolide (PLGA), polycaprolactone (PCL), polylactic acid/polycaprolactone (PLA/PCL), whereas biodegradable metal are made up of magnesium, stainless steel, and cobalt chromium. Biodegradable material hydrolyze in presence of water and convert into simple biological compounds.
Request for a FREE Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1917
Note: *The Sample only consist of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.
The global biodegradable stents market was estimated to be worth US$ 278.6 million in 2018 and is predicted to grow at a CAGR of 15.6 percent between 2018 and 2026.
Increasing risk of cardiovascular disease is driving the biodegradable stents market growth
The high risk of acquiring cardiovascular disease is expected to fuel the expansion of the biodegradable stents market. According to the American Heart Association, cardiovascular disease is the largest cause of mortality worldwide, accounting for over 17.3 million fatalities per year in 2013, accounting for roughly 31% of all deaths, and this number is anticipated to rise to over 23.6 million by 2030. Furthermore, according to the American Heart Association’s 2017 Heart Disease and Stroke Statistics, 39.7% of American adults have excessive cholesterol, putting them at a higher risk of artery blockage. Additionally, the biodegradable stents market is predicted to develop as a result of sedentary lifestyles, rising obesity rates, and an ageing population. Because of the disadvantages of bare metal stents, biodegradable stents are gaining popularity and adoption. For example, bare metal stents have been linked to hypersensitivity reactions and late drug-eluting stent thrombosis. The high cost of biodegradable stents, on the other hand, is a key impediment to market growth.
Biodegradable stents market regional outlook – Asia Pacific to be the fastest growing market
Coherent Market Insights divides the regional biodegradable stents market into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Because of the high number of approved products in the region, Europe enjoys a prominent position in the biodegradable stents industry. On the other hand, once their certified items have successfully navigated the market in North America, the market is predicted to grow steadily. Furthermore, heart obstruction is becoming more common in the region as a result of a sedentary lifestyle. For example, according to Center for Disease Control and Prevention (CDC), the three major factor leading to heart disease are high blood pressure, high cholesterol, and smoking, which has prevalence of 47% of the American population attributing to the disease prone population. However, due to rising medical tourism and increased acceptance of biodegradable stents, the biodegradable stents market in Asia Pacific is likely to rise significantly. Furthermore, growing economies such as India and China provide a wealth of opportunities for industry participants, boosting the regional biodegradable stents market.
Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1917
The key players dominating the global biodegradable stents market
Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., and Arterial Remodeling Technologies SA are among the major companies in the biodegradable stents industry. The global biodegradable stents market growth is also driven by the inorganic strategies of the market players. For example, in 2015, Cardinal Health acquired Cordis, a subsidiary of Johnson & Johnson, for US$ 1.9 billion. The acquisition will roll on the Cordis’s S.M.A.R.T., vascular stents system.
“Limited Period Offer”
Buy This Complete Business Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/1917
Main points in Biodegradable Stents Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Biodegradable Stents Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Biodegradable Stents Industry Impact
Chapter 2 Biodegradable Stents Competition by Types, Applications, and Top Regions and Countries
2.1 Biodegradable Stents (Volume and Value) by Type
2.3 Biodegradable Stents (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Biodegradable Stents Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Biodegradable Stents Market Analysis
Chapter 6 East Asia Biodegradable Stents Market Analysis
Chapter 7 Europe Biodegradable Stents Market Analysis
Chapter 8 South Asia Biodegradable Stents Market Analysis
Chapter 9 Southeast Asia Biodegradable Stents Market Analysis
Chapter 10 Middle East Biodegradable Stents Market Analysis
Chapter 11 Africa Biodegradable Stents Market Analysis
Chapter 12 Oceania Biodegradable Stents Market Analysis
Chapter 13 South America Biodegradable Stents Market Analysis
Chapter 14 Company Profiles and Key Figures in Biodegradable Stents Business
Chapter 15 Biodegradable Stents Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
continued………….
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1917
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837